Abstract:Key PointsThe Hedgehog signalling pathway has diverse functions in animal development and tissue homeostasis. Dysregulation of the pathway has been implicated in several developmental syndromes and cancers.The production of Hedgehog (HH) ligands involves autoproteolytic cleavage and the addition of lipid moieties such as cholesterol and palmitic acid. Several dedicated proteins are required for the secretion of the ligand.Novel mechanisms involving ligand multimerization, complex formation with additional soluble proteins and association with components of the extracellular matrix, such as the heparan sulphate proteoglycans, have been proposed to explain the dispersion of lipidated HH proteins through tissues.Signal transduction requires a number of transmembrane proteins, most notably Patched 1 (PTC) and Smoothened (SMO). The mechanism by which the signal is transduced from PTC to SMO is unclear. Strikingly, in vertebrates, but not Drosophila melanogaster, signal transduction requires the primary cilia of cells, identifying a function for this previously enigmatic organelle.Intracellularly, signalling involves Suppressor of Fu (SUFU), the kinesin proteins Costal 2 (Cos2) in D. melanogaster and KIF7 in vertebrates and several kinases. Signalling culminates with the regulation of the D. melanogaster Cubitus interruptus (Ci) and vertebrate GLI families of transcription factors. HH signalling converts the Ci and GLI proteins from transcriptional repressors to activators by inhibiting their proteolytic cleavage.The various functions of HH signalling have predominately been ascribed to its regulation of gene expression, and the relevant transcriptional networks are beginning to be dissected. Recently, however, non-canonical branches to the signalling pathway have been found, and these might contribute to some HH functions.HH signalling regulates the survival and proliferation of tissue progenitor and stem populations. This function is linked to its role in tumour formation. Several small-molecule antagonists and agonists that target SMO have been identified, and these show promise in the treatment of HH-related pathologies. In 2012, the approval of the Food and Drug Administration (FDA) was obtained for the first drug that targets HH signalling in the skin cancer basal cell carcinoma.

Pharmacological modulation of Sonic Hedgehog signaling pathways in Angiogenesis: A mechanistic perspective

Therapeutic implication of Sonic Hedgehog as a potential modulator in ischemic injury

Small-molecule modulators of the Sonic Hedgehog signaling pathway

Unravelling the Mysteries of the Sonic Hedgehog Pathway in Cancer Stem Cells: Activity, Crosstalk and Regulation

A highlight on Sonic hedgehog pathway

Discovery and evaluation of potential sonic hedgehog signaling pathway inhibitors using pharmacophore modeling and molecular dynamics simulations

Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments

Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention

Strategies to target the Hedgehog signaling pathway for cancer therapy

Current Status of Hedgehog Signaling Inhibitors

Cross Regulation of Signaling Pathways in Gastrointestinal Stromal Tumor.

Sonic hedgehog signalling pathway in CNS tumours: its role and therapeutic implications

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance

Regulation of Smoothened Phosphorylation and High-Level Hedgehog Signaling Activity by a Plasma Membrane Associated Kinase

Progress in research of novel anticancer drugs targeting Hedgehog signaling pathway

Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites

REGULATION OF SONIC HEDGEHOG ON VASCULAR ENDOTHELIAL GROWTH FACTOR,BASIC FIBROBLAST GROWTH FACTOR EXPRESSION AND SECRETION IN BONE MARROW MESENCHYMAL STEM CELLS

Emerging role of non-coding RNAs in the regulation of Sonic Hedgehog signaling pathway

Role of the Sonic Hedgehog Pathway in Regulation of the Proliferation, Migration and Differentiation of Hemangioblast Derived from AGM

Therapeutic potential of hedgehog signaling in advanced cancer types

The mechanisms of Hedgehog signalling and its roles in development and disease